Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II Study About Probiotics to Alleviate Abemaciclib-induced Abdominal Discomfort Under Standard Anti-diarrhea Drug Loperamide and Changes of Metabolic Factors in Blood.

NCT07605728 is registered in ClinicalTrials.gov with Leeuwenhoek Laboratories Co. Ltd. as lead sponsor.

NCT NCT07605728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II Study About Probiotics to Alleviate Abemaciclib-induced Abdominal Discomfort Under Standard Anti-diarrhea Drug Loperamide and Changes of Metabolic Factors in Blood.
Lead sponsor
Leeuwenhoek Laboratories Co. Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
May 15, 2026
Completion date
December 31, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy-induced diarrhea